These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

164 related items for PubMed ID: 37956468

  • 1. Development and validation of a multiplex HPLC-MS/MS assay for the monitoring of JAK inhibitors in patient plasma.
    Tachet J, Versace F, Mercier T, Buclin T, Decosterd LA, Choong E, Girardin FR.
    J Chromatogr B Analyt Technol Biomed Life Sci; 2023 Nov 15; 1230():123917. PubMed ID: 37956468
    [Abstract] [Full Text] [Related]

  • 2. Validation and clinical application of a multiplex high performance liquid chromatography - tandem mass spectrometry assay for the monitoring of plasma concentrations of 12 antibiotics in patients with severe bacterial infections.
    Decosterd LA, Mercier T, Ternon B, Cruchon S, Guignard N, Lahrichi S, Pesse B, Rochat B, Burger R, Lamoth F, Pagani JL, Eggimann P, Csajka C, Choong E, Buclin T, Widmer N, André P, Marchetti O.
    J Chromatogr B Analyt Technol Biomed Life Sci; 2020 Nov 10; 1157():122160. PubMed ID: 32891946
    [Abstract] [Full Text] [Related]

  • 3. Method development and validation for simultaneous determination of six tyrosine kinase inhibitors and two active metabolites in human plasma/serum using UPLC-MS/MS for therapeutic drug monitoring.
    Zhang M, Liu X, Chen Z, Jiang S, Wang L, Tao M, Miao L.
    J Pharm Biomed Anal; 2022 Mar 20; 211():114562. PubMed ID: 35124453
    [Abstract] [Full Text] [Related]

  • 4. Effective quantification of 11 tyrosine kinase inhibitors and caffeine in human plasma by validated LC-MS/MS method with potent phospholipids clean-up procedure. Application to therapeutic drug monitoring.
    Koller D, Vaitsekhovich V, Mba C, Steegmann JL, Zubiaur P, Abad-Santos F, Wojnicz A.
    Talanta; 2020 Feb 01; 208():120450. PubMed ID: 31816725
    [Abstract] [Full Text] [Related]

  • 5. Development and validation of a multiplex UHPLC-MS/MS assay with stable isotopic internal standards for the monitoring of the plasma concentrations of the antiretroviral drugs bictegravir, cabotegravir, doravirine, and rilpivirine in people living with HIV.
    Courlet P, Alves Saldanha S, Cavassini M, Marzolini C, Choong E, Csajka C, Günthard HF, André P, Buclin T, Desfontaine V, Decosterd LA.
    J Mass Spectrom; 2020 Jun 01; 55(6):e4506. PubMed ID: 32160389
    [Abstract] [Full Text] [Related]

  • 6. Development and clinical validation of a simple and fast UPLC-ESI-MS/MS method for simultaneous quantification of nine kinase inhibitors and two antiandrogen drugs in human plasma: Interest for their therapeutic drug monitoring.
    Llopis B, Robidou P, Tissot N, Pinna B, Gougis P, Aubart FC, Campedel L, Abbar B, Weil DR, Uzunov M, Gligorov J, Salem JE, Funck-Brentano C, Zahr N.
    J Pharm Biomed Anal; 2021 Apr 15; 197():113968. PubMed ID: 33618135
    [Abstract] [Full Text] [Related]

  • 7. Development of an UPLC-MS/MS Method for the Quantitative Analysis of Upadacitinib in Beagle Dog Plasma and Pharmacokinetics Study.
    Wang MJ, Zhao YH, Fan C, Wang YJ, Wang XQ, Qiu XJ, Shen RL.
    Drug Des Devel Ther; 2021 Apr 15; 15():4167-4175. PubMed ID: 34629864
    [Abstract] [Full Text] [Related]

  • 8. Validation of an LC-MS/MS assay for rapid and simultaneous quantification of 21 kinase inhibitors in human plasma and serum for therapeutic drug monitoring.
    Al Shirity ZN, Westra N, Hateren KV, Munnink THO, Kosterink JGW, Mian P, Hooge MNL, Touw DJ, Gareb B.
    J Chromatogr B Analyt Technol Biomed Life Sci; 2023 Sep 01; 1229():123872. PubMed ID: 37716342
    [Abstract] [Full Text] [Related]

  • 9. Development and validation of a sensitive liquid chromatography tandem mass spectrometry assay for the simultaneous determination of ten kinase inhibitors in human serum and plasma.
    Aghai F, Zimmermann S, Kurlbaum M, Jung P, Pelzer T, Klinker H, Isberner N, Scherf-Clavel O.
    Anal Bioanal Chem; 2021 Jan 01; 413(2):599-612. PubMed ID: 33155133
    [Abstract] [Full Text] [Related]

  • 10. Determination of Osimertinib, Aumolertinib, and Furmonertinib in Human Plasma for Therapeutic Drug Monitoring by UPLC-MS/MS.
    Li Y, Meng L, Ma Y, Li Y, Xing X, Guo C, Dong Z.
    Molecules; 2022 Jul 13; 27(14):. PubMed ID: 35889345
    [Abstract] [Full Text] [Related]

  • 11. Development and validation of an ultra-high performance liquid chromatography-tandem mass spectrometry method to quantify antiretroviral drug concentrations in human plasma for therapeutic monitoring.
    West RE, Oberly PJ, Riddler SA, Nolin TD, Devanathan AS.
    J Pharm Biomed Anal; 2024 Mar 15; 240():115932. PubMed ID: 38198884
    [Abstract] [Full Text] [Related]

  • 12. Reliable and easy-to-use LC-MS/MS-method for simultaneous determination of the antihypertensives metoprolol, amlodipine, canrenone and hydrochlorothiazide in patients with therapy-refractory arterial hypertension.
    Johannsen JO, Reuter H, Hoffmann F, Blaich C, Wiesen MHJ, Streichert T, Müller C.
    J Pharm Biomed Anal; 2019 Feb 05; 164():373-381. PubMed ID: 30439665
    [Abstract] [Full Text] [Related]

  • 13. Pharmacokinetics of Anti-rheumatic Drugs Methotrexate and Tofacitinib with its Metabolite M9 in Rats by UPLC-MS/MS.
    Gu EM, Xue L, Zhou C, Xia Y, Dai GX.
    Curr Med Chem; 2024 Feb 05; 31(22):3426-3435. PubMed ID: 38310397
    [Abstract] [Full Text] [Related]

  • 14. A Hydrophilic Interaction Liquid Chromatography-Tandem Mass Spectrometry Quantitative Method for Determination of Baricitinib in Plasma, and Its Application in a Pharmacokinetic Study in Rats.
    Ezzeldin E, Iqbal M, Asiri YA, Ali AA, Alam P, El-Nahhas T.
    Molecules; 2020 Mar 31; 25(7):. PubMed ID: 32244454
    [Abstract] [Full Text] [Related]

  • 15. Simultaneous determination of 11 alkaloids in rat plasma by LC-ESI-MS/MS and a pharmacokinetic study after oral administration of total alkaloids extracted from Naucleaofficinalis.
    Wang G, Wang H, Lin Z, Hou L, Wang JY, Sun L.
    J Ethnopharmacol; 2022 Jan 10; 282():114560. PubMed ID: 34454053
    [Abstract] [Full Text] [Related]

  • 16. Development and Validation of High-Throughput Bioanalytical Liquid Chromatography-Tandem Mass Spectrometry (LC-MS/MS) Method for the Quantification of Newly Synthesized Antitumor Carbonic Anhydrase Inhibitors in Human Plasma.
    Abdel-Megied AM, Eldehna WM, Abdelrahman MA, Elbarbry FA.
    Molecules; 2020 Dec 06; 25(23):. PubMed ID: 33291270
    [Abstract] [Full Text] [Related]

  • 17. Simultaneous measurement of upadacitinib and methotrexate by UPLC-MS/MS and its pharmacokinetic application in rats.
    Li J, Chen C, Wang J, Ye Z, Pan L, Liu Z, Tang C.
    J Chromatogr B Analyt Technol Biomed Life Sci; 2022 Jan 01; 1188():123071. PubMed ID: 34875493
    [Abstract] [Full Text] [Related]

  • 18. Development of a Novel Analytical Method for Determining Trazodone in Human Plasma by Liquid Chromatography Coupled With Mass Spectrometry Coupled With Automatic 2-Dimensional Liquid Chromatograph-Mass Spectrometer Coupler 9500 and Its Application to Therapeutic Drug Monitoring.
    Ding J, Zhang Y, Cui X, Zhao C, Zhang S.
    Ther Drug Monit; 2022 Jun 01; 44(3):465-473. PubMed ID: 34469419
    [Abstract] [Full Text] [Related]

  • 19. Therapeutic Drug Monitoring of the new targeted anticancer agents imatinib, nilotinib, dasatinib, sunitinib, sorafenib and lapatinib by LC tandem mass spectrometry.
    Haouala A, Zanolari B, Rochat B, Montemurro M, Zaman K, Duchosal MA, Ris HB, Leyvraz S, Widmer N, Decosterd LA.
    J Chromatogr B Analyt Technol Biomed Life Sci; 2009 Jul 15; 877(22):1982-96. PubMed ID: 19505856
    [Abstract] [Full Text] [Related]

  • 20. Development and validation of a rapid and sensitive UPLC-MS/MS assay for the quantification of tofacitinib in human plasma.
    Bharwad KD, Shah PA, Shrivastav PS, Singhal P.
    Biomed Chromatogr; 2019 Apr 15; 33(4):e4458. PubMed ID: 30520053
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.